Intelligent Bio Solutions (INBS) vs NeuroOne Medical Technologies (NMTC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
NeuroOne Medical Technologies is the larger company by market cap ($5.9 million vs $4.6 million), about 1.3 times the size. NeuroOne Medical Technologies converts more of its revenue into profit, with a net margin of -39.6% versus -294.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INBS | NMTC |
|---|---|---|
| Share price | $1.39 | $0.6521 |
| Market cap | $4.61M | $5.94M |
| 1-day change | -7.95% | -3.38% |
| YTD return | — | -85.66% |
| 1-year return | — | -82.91% |
| 5-year return | — | -95.19% |
| Forward P/E | 3.97 | — |
| EPS (TTM) | $-6.38 | $-0.99 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $4.22M | $9.10M |
| Revenue growth (YoY) | +38.09% | +163.47% |
| Net income (latest FY) | $-12.43M | $-3.61M |
| Gross margin | 48.63% | 56.51% |
| Operating margin | -299.11% | -46.46% |
| Net margin | -294.91% | -39.63% |
| 52-week high | $24.90 | $6.12 |
| 52-week low | $1.35 | $0.61 |
| Distance from 52-week high | -94.42% | -89.34% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +763.31% | +1014.86% |
| Average volume | 129.01K | 337.67K |
| Shares outstanding | 3.32M | 9.11M |
| Employees | 59 | 18 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NeuroOne Medical Technologies is more profitable, keeping -39.6 cents of every revenue dollar as net income versus -294.9 cents for Intelligent Bio Solutions.
- NeuroOne Medical Technologies grew revenue faster in its latest fiscal year (+163.47% vs +38.09%).
About Intelligent Bio Solutions
INBS stock →Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform.
Health Care · Medical/Dental Instruments · 59 employees
About NeuroOne Medical Technologies
NMTC stock →NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders.
Health Care · Medical/Dental Instruments · 18 employees
INBS vs NMTC FAQ
Which is bigger, Intelligent Bio Solutions or NeuroOne Medical Technologies?
NeuroOne Medical Technologies (NMTC) is larger, with a market capitalization of $5.94M compared with $4.61M for Intelligent Bio Solutions (INBS).
Are Intelligent Bio Solutions and NeuroOne Medical Technologies in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.